Skip to main content
Valiant Organics Limited logo

Valiant Organics Limited — Investor Relations & Filings

Ticker · VALIANTORG ISIN · INE565V01010 LEI · 984500F5EB102C4K6815 BSE.NS Manufacturing
Open in API
Filings indexed 373 across all filing types
Latest filing 2026-05-16 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS VALIANTORG

About Valiant Organics Limited

https://www.valiantorganics.com

Valiant Organics Limited focuses on the manufacturing of specialty chemical intermediates through diverse chemical processes, including chlorination, hydrogenation, ammonolysis, and acetylation. The product portfolio primarily consists of chlorophenols, such as para chlorophenol and ortho chlorophenol, as well as various anisidines and toluidines. These chemical compounds are utilized as critical inputs in the formulation of pharmaceuticals, agrochemicals, dyes, and pigments. The company leverages integrated manufacturing facilities and dedicated research and development capabilities to produce high-purity intermediates. Its operational model emphasizes process efficiency and the scaling of complex chemical reactions to meet the technical requirements of global supply chains in the life sciences and performance chemicals sectors.

Recent filings

Filing Released Lang Actions
Re-appointment of Internal and Cost Auditors for the FY 2026-27
Interim / Quarterly Report Classification · 85% confidence The document is an official SEBI Listing Regulations filing by Valiant Organics Ltd. reporting the outcome of a Board meeting in which the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026 were approved. It includes the auditor’s report, the standalone statement of assets & liabilities, cash flow statement and detailed line-item financial results. This is more than a brief earnings summary (ER) and is not a full annual report (10-K). It is the detailed financial results for a period shorter than or encompassing a fiscal year that have been audited and submitted to regulators — fitting the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-16 English
Valiant Organics Announces Evaluation of Restructuring Options
M&A Activity Classification · 87% confidence The document is a press release filed under SEBI LODR Regulation 30, announcing that the Board has approved the evaluation of potential restructuring options including amalgamation, merger, demerger, and other corporate combinations. This constitutes an announcement related to potential M&A transactions rather than a financial report or dividend notice. Therefore, it should be classified under M&A Activity (Code: TAR).
2026-05-16 English
Press Release
M&A Activity Classification · 90% confidence The document is a press release filed under SEBI LODR Regulation 30 announcing that the Board has approved exploring potential restructuring options (amalgamation, merger, demerger, reorganization) among the Company and its subsidiaries. This is not financial results, board changes, or a report publication but a corporate announcement regarding potential M&A transactions. Therefore it fits the ‘M&A Activity’ category.
2026-05-16 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 85% confidence The document is a formal SEBI LODR filing “Outcome of the Board Meeting” by Valiant Organics Limited that includes the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 along with the auditor’s report, statement of assets & liabilities, cash flow statement, and segment disclosures. It is not a press‐style earnings summary (ER) nor a full annual report (10-K) with MD&A and extensive corporate disclosures, but it does contain substantive financial statements for an interim period (the quarter/Q4) and the full year audited results. Therefore, it fits the definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-16 English
Please find the attached announcement.
Audit Report / Information Classification · 85% confidence The document is a formal regulatory filing under SEBI Listing Regulations that includes the Board’s approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, together with the full Independent Auditor’s Report on those financial results. It is not a full Annual Report (10-K), nor a brief earnings release, nor merely an announcement of a report. Its primary content is the standalone audit opinion and related financial statements, matching the definition of an Audit Report / Information (AR). FY 2026
2026-05-16 English
Audited Standalone and Consolidated Financial Results for quarter and year ended March 31, 2026
Interim / Quarterly Report Classification · 85% confidence The document is a formal Board Meeting Outcomes announcement under SEBI LODR, providing the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026, along with full financial statements (assets, liabilities, cash flows) and the independent auditor’s report. It is not a narrative Annual Report (10-K), nor a brief earnings highlight (ER), nor merely a publication notice (RPA). It represents a comprehensive interim/quarterly financial report (including Q4 results and full-year figures) as required under Regulation 33, fitting the Interim/Quarterly Report category. FY 2026
2026-05-16 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.